Modulation of melphalan cytotoxic activity in human melanoma cell lines

Rosanna Supino, Claudia Caserini, Linda Orlandi, Nadia Zaffaroni, Rosella Silvestrini, Maurizio Vaglini, Franco Zunino

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of the present study was to potentiate the cytotoxic effects of melphalan through pharmacological and physical modulators. The combination of the cytotoxic agent with ethacrynic acid, a glutathione-S-transferase π (GSTπ) inhibitor, or topotecan, a topoisomerase I inhibitor, or mild hyperthermia was investigated. The selected cell lines exhibited variable levels of expression of GSTπ, DNA topoisomerase I and heat-shock proteins. Mild hyperthermia (42°C) alone potentiated melphalan cytotoxicity, especially in the two cell lines exhibiting low basal levels of HSP70 expression. The combination of the GST inhibitor with melphalan resulted in a potentiation of drug cytotoxicity only in JR8 cells, one of the two cell lines which expressed high levels of GSTπ mRNA and which were the less responsive to ethacrinic acid alone. A synergistic interaction between topotecan and melphalan was observed only in the cell lines expressing low levels of topoisomerase I even if all cell lines exhibited a comparable sensitivity to this agent. The results support an involvement of GST and DNA topoisomerase in cell defense and response to the alkylating agent. However, the variable potentiation of the cytotoxic effects of melphalan achieved in different cell systems suggests that factors other than the level of expression of the modulation target are responsible of such potentiation.

Original languageEnglish
Pages (from-to)604-612
Number of pages9
JournalAnti-Cancer Drugs
Volume7
Issue number5
Publication statusPublished - 1996

Fingerprint

Melphalan
Glutathione Transferase
Human Activities
Melanoma
Type I DNA Topoisomerase
Cell Line
Ethacrynic Acid
Topotecan
Fever
Drug Synergism
Topoisomerase I Inhibitors
Alkylating Agents
Cytotoxins
Heat-Shock Proteins
Pharmacology
Messenger RNA

Keywords

  • cytotoxicity
  • drug resistance
  • melanoma
  • modulation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Pharmacology

Cite this

Supino, R., Caserini, C., Orlandi, L., Zaffaroni, N., Silvestrini, R., Vaglini, M., & Zunino, F. (1996). Modulation of melphalan cytotoxic activity in human melanoma cell lines. Anti-Cancer Drugs, 7(5), 604-612.

Modulation of melphalan cytotoxic activity in human melanoma cell lines. / Supino, Rosanna; Caserini, Claudia; Orlandi, Linda; Zaffaroni, Nadia; Silvestrini, Rosella; Vaglini, Maurizio; Zunino, Franco.

In: Anti-Cancer Drugs, Vol. 7, No. 5, 1996, p. 604-612.

Research output: Contribution to journalArticle

Supino, R, Caserini, C, Orlandi, L, Zaffaroni, N, Silvestrini, R, Vaglini, M & Zunino, F 1996, 'Modulation of melphalan cytotoxic activity in human melanoma cell lines', Anti-Cancer Drugs, vol. 7, no. 5, pp. 604-612.
Supino R, Caserini C, Orlandi L, Zaffaroni N, Silvestrini R, Vaglini M et al. Modulation of melphalan cytotoxic activity in human melanoma cell lines. Anti-Cancer Drugs. 1996;7(5):604-612.
Supino, Rosanna ; Caserini, Claudia ; Orlandi, Linda ; Zaffaroni, Nadia ; Silvestrini, Rosella ; Vaglini, Maurizio ; Zunino, Franco. / Modulation of melphalan cytotoxic activity in human melanoma cell lines. In: Anti-Cancer Drugs. 1996 ; Vol. 7, No. 5. pp. 604-612.
@article{d02ec0e8e1614c078b214030250f908b,
title = "Modulation of melphalan cytotoxic activity in human melanoma cell lines",
abstract = "The aim of the present study was to potentiate the cytotoxic effects of melphalan through pharmacological and physical modulators. The combination of the cytotoxic agent with ethacrynic acid, a glutathione-S-transferase π (GSTπ) inhibitor, or topotecan, a topoisomerase I inhibitor, or mild hyperthermia was investigated. The selected cell lines exhibited variable levels of expression of GSTπ, DNA topoisomerase I and heat-shock proteins. Mild hyperthermia (42°C) alone potentiated melphalan cytotoxicity, especially in the two cell lines exhibiting low basal levels of HSP70 expression. The combination of the GST inhibitor with melphalan resulted in a potentiation of drug cytotoxicity only in JR8 cells, one of the two cell lines which expressed high levels of GSTπ mRNA and which were the less responsive to ethacrinic acid alone. A synergistic interaction between topotecan and melphalan was observed only in the cell lines expressing low levels of topoisomerase I even if all cell lines exhibited a comparable sensitivity to this agent. The results support an involvement of GST and DNA topoisomerase in cell defense and response to the alkylating agent. However, the variable potentiation of the cytotoxic effects of melphalan achieved in different cell systems suggests that factors other than the level of expression of the modulation target are responsible of such potentiation.",
keywords = "cytotoxicity, drug resistance, melanoma, modulation",
author = "Rosanna Supino and Claudia Caserini and Linda Orlandi and Nadia Zaffaroni and Rosella Silvestrini and Maurizio Vaglini and Franco Zunino",
year = "1996",
language = "English",
volume = "7",
pages = "604--612",
journal = "Anti-Cancer Drugs",
issn = "0959-4973",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Modulation of melphalan cytotoxic activity in human melanoma cell lines

AU - Supino, Rosanna

AU - Caserini, Claudia

AU - Orlandi, Linda

AU - Zaffaroni, Nadia

AU - Silvestrini, Rosella

AU - Vaglini, Maurizio

AU - Zunino, Franco

PY - 1996

Y1 - 1996

N2 - The aim of the present study was to potentiate the cytotoxic effects of melphalan through pharmacological and physical modulators. The combination of the cytotoxic agent with ethacrynic acid, a glutathione-S-transferase π (GSTπ) inhibitor, or topotecan, a topoisomerase I inhibitor, or mild hyperthermia was investigated. The selected cell lines exhibited variable levels of expression of GSTπ, DNA topoisomerase I and heat-shock proteins. Mild hyperthermia (42°C) alone potentiated melphalan cytotoxicity, especially in the two cell lines exhibiting low basal levels of HSP70 expression. The combination of the GST inhibitor with melphalan resulted in a potentiation of drug cytotoxicity only in JR8 cells, one of the two cell lines which expressed high levels of GSTπ mRNA and which were the less responsive to ethacrinic acid alone. A synergistic interaction between topotecan and melphalan was observed only in the cell lines expressing low levels of topoisomerase I even if all cell lines exhibited a comparable sensitivity to this agent. The results support an involvement of GST and DNA topoisomerase in cell defense and response to the alkylating agent. However, the variable potentiation of the cytotoxic effects of melphalan achieved in different cell systems suggests that factors other than the level of expression of the modulation target are responsible of such potentiation.

AB - The aim of the present study was to potentiate the cytotoxic effects of melphalan through pharmacological and physical modulators. The combination of the cytotoxic agent with ethacrynic acid, a glutathione-S-transferase π (GSTπ) inhibitor, or topotecan, a topoisomerase I inhibitor, or mild hyperthermia was investigated. The selected cell lines exhibited variable levels of expression of GSTπ, DNA topoisomerase I and heat-shock proteins. Mild hyperthermia (42°C) alone potentiated melphalan cytotoxicity, especially in the two cell lines exhibiting low basal levels of HSP70 expression. The combination of the GST inhibitor with melphalan resulted in a potentiation of drug cytotoxicity only in JR8 cells, one of the two cell lines which expressed high levels of GSTπ mRNA and which were the less responsive to ethacrinic acid alone. A synergistic interaction between topotecan and melphalan was observed only in the cell lines expressing low levels of topoisomerase I even if all cell lines exhibited a comparable sensitivity to this agent. The results support an involvement of GST and DNA topoisomerase in cell defense and response to the alkylating agent. However, the variable potentiation of the cytotoxic effects of melphalan achieved in different cell systems suggests that factors other than the level of expression of the modulation target are responsible of such potentiation.

KW - cytotoxicity

KW - drug resistance

KW - melanoma

KW - modulation

UR - http://www.scopus.com/inward/record.url?scp=0029816571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029816571&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 604

EP - 612

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

SN - 0959-4973

IS - 5

ER -